2lhv

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:17, 30 October 2024) (edit) (undo)
 
(7 intermediate revisions not shown.)
Line 1: Line 1:
 +
==Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat==
==Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat==
-
<StructureSection load='2lhv' size='340' side='right' caption='[[2lhv]], [[NMR_Ensembles_of_Models | 67 NMR models]]' scene=''>
+
<StructureSection load='2lhv' size='340' side='right'caption='[[2lhv]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
[[2lhv]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LHV OCA]. <br>
+
<table><tr><td colspan='2'>[[2lhv]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LHV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LHV FirstGlance]. <br>
-
<b>[[Non-Standard_Residue|NonStd Res:]]</b> <scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene><br>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 67 models</td></tr>
-
<b>[[Related_structure|Related:]]</b> [[2lhw|2lhw]], [[2lhx|2lhx]], [[2lhy|2lhy]], [[2lhz|2lhz]], [[2li0|2li0]], [[2li1|2li1]], [[2li2|2li2]]<br>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr>
-
<b>Activity:</b> <span class='plainlinks'>[http://en.wikipedia.org/wiki/Glucokinase Glucokinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 2.7.1.2] </span><br>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2lhv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2lhv OCA], [https://pdbe.org/2lhv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2lhv RCSB], [https://www.ebi.ac.uk/pdbsum/2lhv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2lhv ProSAT]</span></td></tr>
-
<b>Resources:</b> <span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2lhv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2lhv OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2lhv RCSB], [http://www.ebi.ac.uk/pdbsum/2lhv PDBsum]</span><br>
+
</table>
 +
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Mucin glycoproteins present a complex structural landscape arising from the multiplicity of glycosylation patterns afforded by their numerous serine and threonine glycosylation sites, often in clusters, and with variations in respective glycans. To explore the structural complexities in such glycoconjugates, we used NMR to systematically analyze the conformational effects of glycosylation density within a cluster of sites. This allows correlation with molecular recognition through analysis of interactions between these and other glycopeptides, with antibodies, lectins, and sera, using a glycopeptide microarray. Selective antibody interactions with discrete conformational elements, reflecting aspects of the peptide and disposition of GalNAc residues, are observed. Our results help bridge the gap between conformational properties and molecular recognition of these molecules, with implications for their physiological roles. Features of the native mucin motifs impact their relative immunogenicity and are accurately encoded in the antibody binding site, with the conformational integrity being preserved in isolated glycopeptides, as reflected in the antibody binding profile to array components.
Mucin glycoproteins present a complex structural landscape arising from the multiplicity of glycosylation patterns afforded by their numerous serine and threonine glycosylation sites, often in clusters, and with variations in respective glycans. To explore the structural complexities in such glycoconjugates, we used NMR to systematically analyze the conformational effects of glycosylation density within a cluster of sites. This allows correlation with molecular recognition through analysis of interactions between these and other glycopeptides, with antibodies, lectins, and sera, using a glycopeptide microarray. Selective antibody interactions with discrete conformational elements, reflecting aspects of the peptide and disposition of GalNAc residues, are observed. Our results help bridge the gap between conformational properties and molecular recognition of these molecules, with implications for their physiological roles. Features of the native mucin motifs impact their relative immunogenicity and are accurately encoded in the antibody binding site, with the conformational integrity being preserved in isolated glycopeptides, as reflected in the antibody binding profile to array components.
Line 12: Line 14:
Deciphering structural elements of mucin glycoprotein recognition.,Borgert A, Heimburg-Molinaro J, Song X, Lasanajak Y, Ju T, Liu M, Thompson P, Ragupathi G, Barany G, Smith DF, Cummings RD, Live D ACS Chem Biol. 2012 Jun 15;7(6):1031-9. Epub 2012 Apr 9. PMID:22444368<ref>PMID:22444368</ref>
Deciphering structural elements of mucin glycoprotein recognition.,Borgert A, Heimburg-Molinaro J, Song X, Lasanajak Y, Ju T, Liu M, Thompson P, Ragupathi G, Barany G, Smith DF, Cummings RD, Live D ACS Chem Biol. 2012 Jun 15;7(6):1031-9. Epub 2012 Apr 9. PMID:22444368<ref>PMID:22444368</ref>
-
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 2lhv" style="background-color:#fffaf0;"></div>
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Barany, G.]]
+
[[Category: Large Structures]]
-
[[Category: Borgert, A.]]
+
[[Category: Barany G]]
-
[[Category: Cummings, R.]]
+
[[Category: Borgert A]]
-
[[Category: Heimburg-Molinaro, J.]]
+
[[Category: Cummings R]]
-
[[Category: Ju, T.]]
+
[[Category: Heimburg-Molinaro J]]
-
[[Category: Lasanajak, Y.]]
+
[[Category: Ju T]]
-
[[Category: Liu, M.]]
+
[[Category: Lasanajak Y]]
-
[[Category: Live, D.]]
+
[[Category: Liu M]]
-
[[Category: Ragupathi, G.]]
+
[[Category: Live D]]
-
[[Category: Smith, D.]]
+
[[Category: Ragupathi G]]
-
[[Category: Thompson, P.]]
+
[[Category: Smith D]]
-
[[Category: Glycosylation]]
+
[[Category: Thompson P]]
-
[[Category: Sugar binding protein]]
+
-
[[Category: Tn antigen]]
+

Current revision

Mucin sequence based on MUC2 Mucin glycoprotein tandem repeat

PDB ID 2lhv

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools